avkАрхивъ внутренней медициныThe Russian Archives of Internal Medicine2226-67042411-6564“SINAPS” LLC10.20514/2226-6704-2020-10-2-119-130avk-1023Research ArticleОБЗОРНЫЕ СТАТЬИREVIEW ARTICLESАнтибактериальная профилактика инфекционного эндокардита: от истории концепции до современных рекомендаций (обзор литературы)Antibiotic Prophylaxis of Infective Endocarditis: From the History of the Concept to Modern Recommendations (Review)https://orcid.org/0000-0003-3984-8482ТарадинГ. Г.TaradinG. G.

Геннадий Геннадьевич Тарадин

Gennadiy G. Taradin

Donetsk

taradin@inbox.ruПономареваЕ. Ю.PonomarevaE. Yu.ИгнатенкоГ. А.IgnatenkoG. A.ВатутинН. Т.VatutinN. T.ПрендергастБ. Д.PrendergastB. D.

Отделение кардиологии

Лондон

Department of Cardiology

London

ГОО ВПО «Донецкий национальный медицинский университет им. М. Горького»; ГУ «Институт неотложной и восстановительной хирургии им. В.К. Гусака»РоссияState Educational Organization of Higher Professional Education «M. Gorky Donetsk National Medical University»; State Institution «V.K. Gusak Institute of Urgent and Recovery Surgery»Russian FederationФГБОУ ВО Саратовский ГМУ им. В.И. Разумовского Минздрава РоссииРоссияFederal State Budgetary Educational Institution of Higher Education «Saratov State Medical University named after V.I. Razumovsky»Russian FederationГОО ВПО «Донецкий национальный медицинский университет им. М. Горького»РоссияState Educational Organization of Higher Professional Education «M. Gorky Donetsk National Medical University»Russian FederationГоспиталь Св. ТомасаВеликобританияSt. Thomas HospitalUnited Kingdom202031032020102119130Copyright © Тарадин Г.Г., Пономарева Е.Ю., Игнатенко Г.А., Ватутин Н.Т., Прендергаст Б.Д., 20202020Тарадин Г.Г., Пономарева Е.Ю., Игнатенко Г.А., Ватутин Н.Т., Прендергаст Б.Д.Taradin G.G., Ponomareva E.Y., Ignatenko G.A., Vatutin N.T., Prendergast B.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.medarhive.ru/jour/article/view/1023

В настоящем обзоре освещаются современные представления о профилактике инфекционного эндокардита. Описывается история развития концепции антибактериальной профилактики инфекционного эндокардита, основные подходы и обоснование изменения принципов антибактериальной профилактики в последние годы. Подробно освещаются последние принятые международные и национальные рекомендации, в частности, Европейского общества кардиологов, Американской ассоциации сердца/Американской коллегии кардиологов и Японского общества по кровообращению. Представлена критическая оценка принятых ранее международных рекомендаций с анализом влияния частичного или полного ограничения антибактериальной профилактики на заболеваемость инфекционного эндокардита и частоту его осложнений.

The presented review highlights current understandings of prophylaxis for infective endocarditis (IE). The historic aspects of the concept development of antibacterial prophylaxis (ABP) for IE, the main approaches and the rationale for changing the principles of ABP in recent years are described. There are detailed clarifications of published international and national recommendations, in particular, of European Society of Cardiology, National Institute for Health and Clinical Excellence, American Heart Association/American College of Cardiology and Japanese Circulation Society. The critical estimation of earlier adopted international guidelines with analysis of influence of partial or absolute ABP restrictions on the incidence of IE and its complications including fatality rate are presented.

инфекционный эндокардитпрофилактикаантибиотикиантибактериальная профилактикамеждународные рекомендацииinfective endocarditisprophylaxisantibioticsantibacterial prophylaxisinternational guidelinesReferencesДемин А.А. Инфекционный эндокардит (профилактика, диагностические критерии и лечение): ключевые положения 2010. Рацио нальная Фармакотерапия в Кардиологии. 2010;6(5):747-748 doi: 10.20996/1819-6446-2010-6-5-747-748.Demin AA. The infective endocarditis (prevention, diagnosis criteria and treatment): key points 2010. Rational Pharmacotherapy in Cardiology. 2010;6(5):747-748. doi: 10.20996/1819-6446-2010-65-747-748. [In Russian].Тюрин В.П. Инфекционные эндокардиты. М.: ГЭОТАР-Медиа, 2013. 368 с.Tjurin V.P. Infective endocarditis. M.: GEOTAR-Media, 2013. 368 p. [In Russian].Роголевич В.В., Глушкова Т.В., Понасенко А.В., Овчаренко Е.А. Инфек ционный эндокардит как причина развития дисфункции клапанов сердца. Кардиология. 2019; 59(3):68-77. doi: 10.18087/cardio.2019.3.10245.Rogolevich V.V., Glushkova T.V., Ponasenko A.V., Ovcharenko E.A. Infective Endocarditis Causing Native and Prosthetic Heart Valve Dysfunction. Kardiologiia. 2019;59(3):68-77. doi: 10.18087/cardio.2019.3.10245. [In Russian].Белов Б.С., Тарасова Г.М. Антибактериальная терапия и профилактика инфекционного эндокардита в современных условиях. Эффективная фармакотерапия. 2019;15: 52–58. doi: 10.33978/2307-3586-2019-15-8-52-58.Belov B.S., Tarasova G.M. Antibacterial therapy and prophylaxis for infective endocarditis in in present-day conditions. Effective pharmacotherapy. 2019; 15: 52-58. doi: 10.33978/2307-3586-201915-8-52-58. [In Russian].Cahill T.J., Prendergast B.D. Infective endocarditis. Lancet. 2016 Feb 27;387(10021):882-93. doi: 10.1016/S0140-6736(15)00067-7.Cahill T.J., Prendergast B.D. Infective endocarditis. Lancet. 2016 Feb 27;387(10021):882-93. doi: 10.1016/S0140-6736(15)00067-7.Cahill T.J., Baddour L.M., Habib G. et al. Challenges in infective endocarditis. J Am Coll Cardiol. 2017 Jan 24;69(3):325-344. doi: 10.1016/j.jacc.2016.10.066.Cahill T.J., Baddour L.M., Habib G. et al. Challenges in infective endocarditis. J Am Coll Cardiol. 2017 Jan 24;69(3):325-344. doi: 10.1016/j.jacc.2016.10.066.Пономарева Е.Ю., Ландфанг С.В. Анализ госпитальной летальности при инфекционном эндокардите. Фундаментальные исследования. 2015;1-6: 1222-1225. ISSN: 1812-7339.Ponomareva E.Yu., Landfang C.V. The analysis of inpatient mortality in infective endocarditis. Fundamental Researches. 2015;1-6: 1222-1225. ISSN: 1812-7339. [In Russian].Tran H.M., Truong V.T., Ngo T.M. N. et al. Microbiological profile and risk factors for in-hospital mortality of infective endocarditis in tertiary care hospitals of south Vietnam. PLoS One. 2017 Dec 14;12(12): e0189421. doi: 10.1371/journal.pone.0189421.Tran H.M., Truong V.T., Ngo T.M. N. et al. Microbiological profile and risk factors for in-hospital mortality of infective endocarditis in tertiary care hospitals of south Vietnam. PLoS One. 2017 Dec 14;12(12): e0189421. doi: 10.1371/journal.pone.0189421.Habib G., Erba P.A., Iung B. et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESCEORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019 Sep 3. pii: ehz620. doi: 10.1093/eurheartj/ehz620.Habib G., Erba P.A., Iung B. et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESCEORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019 Sep 3. pii: ehz620. doi: 10.1093/eurheartj/ehz620.Nishimura R.A., Otto C.M., Bonow R.O. et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2014 Jul;148(1):e1-e132. doi: 10.1016/j.jtcvs.2014.05.014.Nishimura R.A., Otto C.M., Bonow R.O. et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2014 Jul;148(1):e1-e132. doi: 10.1016/j.jtcvs.2014.05.014.Chambers J., Sandoe J., Ray S. et al. The infective endocarditis team: recommendations from an international working group. Heart. 2014 Apr;100(7):524-7. doi: 10.1136/heartjnl-2013-304354Chambers J., Sandoe J., Ray S. et al. The infective endocarditis team: recommendations from an international working group. Heart. 2014 Apr;100(7):524-7. doi: 10.1136/heartjnl-2013-304354Pericart L., Fauchier L., Bourguignon T. et al. Long-Term Outcome and Valve Surgery for Infective Endocarditis in the Systematic Analysis of a Community Study. Ann Thorac Surg. 2016 Aug; 102(2): 496-504. doi: 10.1016/j.athoracsur.2016.02.010.Pericart L., Fauchier L., Bourguignon T. et al. Long-Term Outcome and Valve Surgery for Infective Endocarditis in the Systematic Analysis of a Community Study. Ann Thorac Surg. 2016 Aug; 102(2): 496-504. doi: 10.1016/j.athoracsur.2016.02.010.Cresti A., Chiavarelli M., Scalese M. et al. Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. Cardiovasc Diagn Ther. 2017 Feb; 7(1): 27-35. doi: 10.21037/cdt.2016.08.09.Cresti A., Chiavarelli M., Scalese M. et al. Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. Cardiovasc Diagn Ther. 2017 Feb; 7(1): 27-35. doi: 10.21037/cdt.2016.08.09.Jones T.D., Baumgartner L., Bellows M.T. et al. (Committee on Prevention of Rheumatic Fever and Bacterial Endocarditis, American Heart Association). Prevention of rheumatic fever and bacterial endocarditis through control of streptococcal infections. Circulation. 1955; 11: 317–320.Jones T.D., Baumgartner L., Bellows M.T. et al. (Committee on Prevention of Rheumatic Fever and Bacterial Endocarditis, American Heart Association). Prevention of rheumatic fever and bacterial endocarditis through control of streptococcal infections. Circulation. 1955; 11: 317–320.Cahill T.J., Harrison J.L., Jewell P. et al. Antibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis. Heart. 2017 Jun; 103(12): 937-944. doi: 10.1136/heartjnl-2015-309102.Cahill T.J., Harrison J.L., Jewell P. et al. Antibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis. Heart. 2017 Jun; 103(12): 937-944. doi: 10.1136/heartjnl-2015-309102.Dayer M., Thornhill M. Is antibiotic prophylaxis to prevent infective endocarditis worthwhile? J Infect Chemother. 2018 Jan; 24(1): 18-24. doi: 10.1016/j.jiac.2017.10.006.Dayer M., Thornhill M. Is antibiotic prophylaxis to prevent infective endocarditis worthwhile? J Infect Chemother. 2018 Jan; 24(1): 18-24. doi: 10.1016/j.jiac.2017.10.006.Thornhill M.H., Jones S., Prendergast B. et al. Quantifying infective endocarditis risk in patients with predisposing cardiac conditions. Eur Heart J. 2018 Feb 14; 39(7): 586-595. doi: 10.1093/eurheartj/ehx655.Thornhill M.H., Jones S., Prendergast B. et al. Quantifying infective endocarditis risk in patients with predisposing cardiac conditions. Eur Heart J. 2018 Feb 14; 39(7): 586-595. doi: 10.1093/eurheartj/ehx655.Cahill T.J., Jewell P.D., Denne L. et al. Contemporary epidemiology of infective endocarditis in patients with congenital heart disease: A UK prospective study. Am Heart J. 2019 Jun 14; 215: 70-77. doi: 10.1016/j.ahj.2019.05.014.Cahill T.J., Jewell P.D., Denne L. et al. Contemporary epidemiology of infective endocarditis in patients with congenital heart disease: A UK prospective study. Am Heart J. 2019 Jun 14; 215: 70-77. doi: 10.1016/j.ahj.2019.05.014.Baddour L.M., Wilson W.R., Bayer A.S. el al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications. A Scientific Statement for healthcare professionals from the American Heart Association. Circulation. 2015 Oct 13; 132(15): 1435-86. doi: 10.1161/CIR.0000000000000296.Baddour L.M., Wilson W.R., Bayer A.S. el al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications. A Scientific Statement for healthcare professionals from the American Heart Association. Circulation. 2015 Oct 13; 132(15): 1435-86. doi: 10.1161/CIR.0000000000000296.Blumenthal K.G., Peter J.G., Trubiano J.A. Antibiotic allergy. Lancet. 2019; 393(10167): 183–198. doi:10.1016/S0140-6736(18)32218-9.Blumenthal K.G., Peter J.G., Trubiano J.A. Antibiotic allergy. Lancet. 2019; 393(10167): 183–198. doi:10.1016/S0140-6736(18)32218-9.Loyola-Rodriguez J.P., Franco-Miranda A., Loyola-Leyva A. el al. Prevention of infective endocarditis and bacterial resistance to antibiotics: A brief review. Spec Care Dentist. 2019;39(6):603-9. doi: 10.1111/scd.12415.Loyola-Rodriguez J.P., Franco-Miranda A., Loyola-Leyva A. el al. Prevention of infective endocarditis and bacterial resistance to antibiotics: A brief review. Spec Care Dentist. 2019;39(6):603-9. doi: 10.1111/scd.12415.Horder T.J. Infective endocarditis: with an analysis of 150 cases and with special reference to the chronic form of the disease. QJM 1909;2:289–324.Horder T.J. Infective endocarditis: with an analysis of 150 cases and with special reference to the chronic form of the disease. QJM 1909;2:289–324.Lewis T., Grant R. Observations relating to subacute infective endocarditis. Heart 1923;10:21-77.Lewis T., Grant R. Observations relating to subacute infective endocarditis. Heart 1923;10:21-77.Okell C.C., Elliott S.D. Bacteraemia and oral sepsis: with special reference to the aetiology of subacute endocarditis. Lancet 1935;226(5851):869-72. doi:10.1016/S0140-6736(00)47788-3Okell C.C., Elliott S.D. Bacteraemia and oral sepsis: with special reference to the aetiology of subacute endocarditis. Lancet 1935;226(5851):869-72. doi:10.1016/S0140-6736(00)47788-3Thomas C.B., France R., Reichsman F. Prophylactic use of sulfanilamide. JAMA. 1941;116(7):551-560. doi:10.1001/jama.1941.02820070001001Thomas C.B., France R., Reichsman F. Prophylactic use of sulfanilamide. JAMA. 1941;116(7):551-560. doi:10.1001/jama.1941.02820070001001Tomas I, Alvarez-Fernandez M. History of antimicrobial prophylaxis protocols for infective endocarditis secondary to dental procedures. In book: Recent Advances in Infective Endocarditis. InTech, Croacia, Eds: S.W. Kerrigan, 2013;4:53-84. doi: 10.5772/56118.Tomas I, Alvarez-Fernandez M. History of antimicrobial prophylaxis protocols for infective endocarditis secondary to dental procedures. In book: Recent Advances in Infective Endocarditis. InTech, Croacia, Eds: S.W. Kerrigan, 2013;4:53-84. doi: 10.5772/56118.Wilson W., Taubert K.A., Gewitz M. et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116(15):1736–54. doi: 10.1161/CIRCULATIONAHA.106.183095.Wilson W., Taubert K.A., Gewitz M. et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116(15):1736–54. doi: 10.1161/CIRCULATIONAHA.106.183095.Zoumpoulakis M., Anagnostou F., Dalampiras S. et al. Infective endocarditis prophylaxis in patients undergoing oral surgery. Balk J Dent Med, 2016;20(1):5-14. doi: 10.1515/bjdm-2016-0001.Zoumpoulakis M., Anagnostou F., Dalampiras S. et al. Infective endocarditis prophylaxis in patients undergoing oral surgery. Balk J Dent Med, 2016;20(1):5-14. doi: 10.1515/bjdm-2016-0001.Delahaye F., M’Hammedi A., Guerpillon B. et al. Systematic search for present and potential portals of entry for infective endocarditis. J Am Coll Cardiol. 2016;67(2):151-8. doi: 10.1016/j.jacc.2015.10.065.Delahaye F., M’Hammedi A., Guerpillon B. et al. Systematic search for present and potential portals of entry for infective endocarditis. J Am Coll Cardiol. 2016;67(2):151-8. doi: 10.1016/j.jacc.2015.10.065.Lockhart P.B., Brennan M.T., Sasser H.C. et al. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008;117(24):3118-25. doi: 10.1161/CIRCULATIONAHA.107.758524.Lockhart P.B., Brennan M.T., Sasser H.C. et al. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008;117(24):3118-25. doi: 10.1161/CIRCULATIONAHA.107.758524.Kaya C.T., Erol C.. How to achieve infective endocarditis prophylaxis. E-J Cardiol. Pract. 2018; 16(33): Код доступа: https://www.escardio.org/vgn-ext-templating/Journals/E-Journal-of-CardiologyPractice/Volume-16/vol16no33 (Доступ активен 20.02.2020).Kaya C.T., Erol C.. How to achieve infective endocarditis prophylaxis. E-J Cardiol. Pract. 2018; 16(33): Код доступа: https://www.escardio.org/vgn-ext-templating/Journals/E-Journal-of-CardiologyPractice/Volume-16/vol16no33 (Доступ активен 20.02.2020).Janszky I., Gemes K., Ahnve S. et al. Invasive procedures associated with the development of infective endocarditis. J Am Coll Cardiol. 2018;71(24):2744-52. doi: 10.1016/j.jacc.2018.03.532.Janszky I., Gemes K., Ahnve S. et al. Invasive procedures associated with the development of infective endocarditis. J Am Coll Cardiol. 2018;71(24):2744-52. doi: 10.1016/j.jacc.2018.03.532.Rossi A.M., Mariwalla K. Prophylactic and empiric use of antibiotics in dermatologic surgery: a review of the literature and practical considerations. Dermatol Surg. 2012;38(12):1898-921. doi: 10.1111/j.1524-4725.2012.02524.x.Rossi A.M., Mariwalla K. Prophylactic and empiric use of antibiotics in dermatologic surgery: a review of the literature and practical considerations. Dermatol Surg. 2012;38(12):1898-921. doi: 10.1111/j.1524-4725.2012.02524.x.Thuny F., Grisoli D., Cautela J. et al. Infective endocarditis: prevention, diagnosis, and management. Can J Cardiol. 2014;30(9):1046-57. doi: 10.1016/j.cjca.2014.03.042.Thuny F., Grisoli D., Cautela J. et al. Infective endocarditis: prevention, diagnosis, and management. Can J Cardiol. 2014;30(9):1046-57. doi: 10.1016/j.cjca.2014.03.042.Richey R., Wray D., Stokes T. Prophylaxis against infective endocarditis: summary of NICE guidance. BMJ. 2008;336(7647):770-1. doi: 10.1136/bmj.39510.423148.AD.Richey R., Wray D., Stokes T. Prophylaxis against infective endocarditis: summary of NICE guidance. BMJ. 2008;336(7647):770-1. doi: 10.1136/bmj.39510.423148.AD.Habib G., Hoen B., Tornos P. et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis. The Task Force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology. Eur Heart J. 2009;30(19):2369– 413. doi:10.1093/eurheartj/ehp285.Habib G., Hoen B., Tornos P. et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis. The Task Force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology. Eur Heart J. 2009;30(19):2369– 413. doi:10.1093/eurheartj/ehp285.Habib G., Lancellotti P., Antunes M.J. et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075-128. doi:10.1093/eurheartj/ehv319.Habib G., Lancellotti P., Antunes M.J. et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075-128. doi:10.1093/eurheartj/ehv319.Thornhill M.H., Dayer M., Lockhart P.B. et al. A change in the NICE guidelines on antibiotic prophylaxis. Br Dent J. 2016;221(3):112-4. doi: 10.1038/sj.bdj.2016.554.Thornhill M.H., Dayer M., Lockhart P.B. et al. A change in the NICE guidelines on antibiotic prophylaxis. Br Dent J. 2016;221(3):112-4. doi: 10.1038/sj.bdj.2016.554.Roberts G.J. Dentists are innocent! “Everyday” bacteremia is the real culprit: a review and assessment of the evidence that dental surgical procedures are a principal cause of bacterial endocarditis in children. Pediatr Cardiol. 1999;20(5):317-25. doi: 10.1007/s002469900477.Roberts G.J. Dentists are innocent! “Everyday” bacteremia is the real culprit: a review and assessment of the evidence that dental surgical procedures are a principal cause of bacterial endocarditis in children. Pediatr Cardiol. 1999;20(5):317-25. doi: 10.1007/s002469900477.Ferri M., Ranucci E., Romagnoli P. et al. Antimicrobial resistance: A global emerging threat to public health systems. Crit Rev Food Sci Nutr. 2017;57(13):2857-76. doi: 10.1080/10408398.2015.1077192.Ferri M., Ranucci E., Romagnoli P. et al. Antimicrobial resistance: A global emerging threat to public health systems. Crit Rev Food Sci Nutr. 2017;57(13):2857-76. doi: 10.1080/10408398.2015.1077192.Стеценко В.В., Ефимочкина Н.Р. Механизмы формирования антибиотикорезистентности бактерий рода Campylobacter. Антибиотики и химиотерапия 2018; 63(9-10):61-68. DOI:10.24411/0235-29902018-00049Stetsenko V.V., Efimochkina N.R. The Mechanisms of Antibiotic Resistance in Bacteria of the Genus Campylobacter. Antibiotiki i himioterapija 2018;63(9-10):61-68 DOI:10.24411/0235-29902018-00049 [In Russian].Ефименко Т.А., Терехова Л.П., Ефременкова О.В. Современное состояние проблемы антибиотикорезистентности патогенных бактерий. Антибиотики и химиотерапия 2019;64(5-6): 64-8. DOI: 10.24411/0235-2990-2019100033Efimenko T.A., Terekhova L.P., Efremenkova O.V. Antibiotiki i himioterapija 2019;64(5-6):64-8. DOI: 10.24411/0235-2990-2019100033 [In Russian].National Institute for Health and Clinical Excellence. Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. 14.03.2008. Updated at 2018. www.nice.org.uk/CG064 (Доступ активен: 20.02.2020).National Institute for Health and Clinical Excellence. Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. 14.03.2008. Updated at 2018. www.nice.org.uk/CG064 (Доступ активен: 20.02.2020).Инфекционный эндокардит. Клинические рекомендации. Министерство здравоохранения Российской Федерации, Москва, 2016; 50 с.Infectious endocarditis. Clinical recommendations. Ministry of Health of the Russian Federation, Moscow, 2016; 50 p. [In Russian].Regitz-Zagrosek V.., Roos-Hesselink J.W, Bauersachs J. et al.; ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018 Sep 7;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340.Regitz-Zagrosek V.., Roos-Hesselink J.W, Bauersachs J. et al.; ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018 Sep 7;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340.Warnes C.A., Williams R.G., Bashore T.M. et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52(23):e143-e263. doi: 10.1016/j.jacc.2008.10.001.Warnes C.A., Williams R.G., Bashore T.M. et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52(23):e143-e263. doi: 10.1016/j.jacc.2008.10.001.Nakatani S., Ohara T., Ashihara K. et al.; Japanese Circulation Society Joint Working Group. JCS 2017 guideline on prevention and treatment of infective endocarditis. Circ J. 2019 Jul 25;83(8):1767-1809. doi: 10.1253/circj.CJ-19-0549.Nakatani S., Ohara T., Ashihara K. et al.; Japanese Circulation Society Joint Working Group. JCS 2017 guideline on prevention and treatment of infective endocarditis. Circ J. 2019 Jul 25;83(8):1767-1809. doi: 10.1253/circj.CJ-19-0549.Peterson G.E., Crowley A.L. Antibiotic prophylaxis for infective endocarditis. Circulation, 2019;140(3):181–183. doi:10.1161/circulationaha.119.041085.Peterson G.E., Crowley A.L. Antibiotic prophylaxis for infective endocarditis. Circulation, 2019;140(3):181–183. doi:10.1161/circulationaha.119.041085.Danchin N., Duval X., Leport C. Prophylaxis of infective endocarditis: French recommendations 2002. Heart. 2005 Jun;91(6):715-8. DOI: 10.1136/hrt.2003.033183.Danchin N., Duval X., Leport C. Prophylaxis of infective endocarditis: French recommendations 2002. Heart. 2005 Jun;91(6):715-8. DOI: 10.1136/hrt.2003.033183.Duval X., Delahaye F., Alla F. et al.; AEPEI Study Group. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012 May 29;59(22):1968-76. doi: 10.1016/j.jacc.2012.02.029.Duval X., Delahaye F., Alla F. et al.; AEPEI Study Group. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012 May 29;59(22):1968-76. doi: 10.1016/j.jacc.2012.02.029.DeSimone D.C., Tleyjeh I.M., Correa de Sa D.D. et al.; Mayo Cardiovascular Infections Study Group. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association’s endocarditis prevention guidelines. Circulation. 2012 Jul 3;126(1):60-4. doi: 10.1161/CIRCULATIONAHA.112.095281.DeSimone D.C., Tleyjeh I.M., Correa de Sa D.D. et al.; Mayo Cardiovascular Infections Study Group. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association’s endocarditis prevention guidelines. Circulation. 2012 Jul 3;126(1):60-4. doi: 10.1161/CIRCULATIONAHA.112.095281.DeSimone D.C., Tleyjeh I.M., Correa de Sa D.D., et al.; Mayo Cardiovascular Infections Study Group. Incidence of infective endocarditis due to viridans group streptococci before and after the 2007 American Heart Association’s prevention guidelines: an extended evaluation of the Olmsted County, Minnesota, population and Nationwide Inpatient Sample. Mayo Clin Proc. 2015 Jul;90(7):874-81. doi: 10.1016/j.mayocp.2015.04.019.DeSimone D.C., Tleyjeh I.M., Correa de Sa D.D., et al.; Mayo Cardiovascular Infections Study Group. Incidence of infective endocarditis due to viridans group streptococci before and after the 2007 American Heart Association’s prevention guidelines: an extended evaluation of the Olmsted County, Minnesota, population and Nationwide Inpatient Sample. Mayo Clin Proc. 2015 Jul;90(7):874-81. doi: 10.1016/j.mayocp.2015.04.019.Pant S., Patel N.J., Deshmukh A. et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015 May 19; 65(19): 2070-6. doi: 10.1016/j.jacc.2015.03.518.Pant S., Patel N.J., Deshmukh A. et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015 May 19; 65(19): 2070-6. doi: 10.1016/j.jacc.2015.03.518.Thornhill M.H., Dayer M.J., Forde J.M. et al. Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ. 2011 May 3;342:d2392. doi: 10.1136/bmj.d2392.Thornhill M.H., Dayer M.J., Forde J.M. et al. Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ. 2011 May 3;342:d2392. doi: 10.1136/bmj.d2392.Dayer M.J., Jones S., Prendergast B. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet. 2015 Mar 28;385(9974):1219-28. doi: 10.1016/S01406736(14)62007-9.Dayer M.J., Jones S., Prendergast B. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet. 2015 Mar 28;385(9974):1219-28. doi: 10.1016/S01406736(14)62007-9.Garg P., Ko D.T., Bray Jenkyn K.M. Infective endocarditis hospitalizations and antibiotic prophylaxis rates before and after the 2007 American Heart Association Guideline Revision. Circulation. 2019 Jul 16;140(3):170-180. doi: 10.1161/CIRCULATIONAHA.118.037657.Garg P., Ko D.T., Bray Jenkyn K.M. Infective endocarditis hospitalizations and antibiotic prophylaxis rates before and after the 2007 American Heart Association Guideline Revision. Circulation. 2019 Jul 16;140(3):170-180. doi: 10.1161/CIRCULATIONAHA.118.037657.Hsiao CC, Weng CH, Li YJ, Wu HH, Chen YC, Chen YM, et al. Comparison of the clinical features and outcomes of infective endocarditis between hemodialysis and non-hemodialysis patients. Ther Clin Risk Manag. 2017 May 24; 13: 663-668. doi: 10.2147/TCRM.S135262Hsiao CC, Weng CH, Li YJ, Wu HH, Chen YC, Chen YM, et al. Comparison of the clinical features and outcomes of infective endocarditis between hemodialysis and non-hemodialysis patients. Ther Clin Risk Manag. 2017 May 24; 13: 663-668. doi: 10.2147/TCRM.S135262Rudasill S.E., Sanaiha Y., Mardock A.L. et al. Clinical outcomes of infective endocarditis in injection drug users. J Am Coll Cardiol. 2019 Feb 12;73(5):559-570. doi: 10.1016/j.jacc.2018.10.082.Rudasill S.E., Sanaiha Y., Mardock A.L. et al. Clinical outcomes of infective endocarditis in injection drug users. J Am Coll Cardiol. 2019 Feb 12;73(5):559-570. doi: 10.1016/j.jacc.2018.10.082.Тарадин Г.Г., Ватутин Н.Т., Прендергаст Б.Д. и др. Инфекционный эндокардит у пожилых: современный взгляд на проблему. Терапевтический архив. 2016; 11: 128-137. doi: 10.17116/terarch20168811128137.Taradin G.G., Vatutin N.T., Prendergast B.D. et al. Infective endocarditis in the elderly: The current view of the problem. Therapeutic archive = Terapevticheskiy arkhiv. 2016; 88(11): 128-137. doi: 10.17116/terarch20168811128137. [In Russian].Ostergaard L., Mogensen U.M., Bundgaard J.S. et al. Duration and complications of diabetes mellitus and the associated risk of infective endocarditis. Int J Cardiol. 2019 Mar 1; 278: 280-284. doi: 10.1016/j.ijcard.2018.09.106.Ostergaard L., Mogensen U.M., Bundgaard J.S. et al. Duration and complications of diabetes mellitus and the associated risk of infective endocarditis. Int J Cardiol. 2019 Mar 1; 278: 280-284. doi: 10.1016/j.ijcard.2018.09.106.Fernandez-Cruz A., Munoz P., Sandoval C. et al.; Spanish Collaboration on Endocarditis (GAMES). Infective endocarditis in patients with cancer: a consequence of invasive procedures or a harbinger of neoplasm? A prospective, multicenter cohort. Medicine (Baltimore). 2017 Sep;96(38):e7913. doi: 10.1097/MD.0000000000007913.Fernandez-Cruz A., Munoz P., Sandoval C. et al.; Spanish Collaboration on Endocarditis (GAMES). Infective endocarditis in patients with cancer: a consequence of invasive procedures or a harbinger of neoplasm? A prospective, multicenter cohort. Medicine (Baltimore). 2017 Sep;96(38):e7913. doi: 10.1097/MD.0000000000007913.van den Brink F.S., Zivelonghi C., Ten Berg J.M. Incidence of infective valve endocarditis as after antibiotic prophylaxis guidelines changedthere is a change. Ann Cardiothorac Surg. 2019 Nov;8(6):683-684. doi: 10.21037/acs.2019.06.05.van den Brink F.S., Zivelonghi C., Ten Berg J.M. Incidence of infective valve endocarditis as after antibiotic prophylaxis guidelines changedthere is a change. Ann Cardiothorac Surg. 2019 Nov;8(6):683-684. doi: 10.21037/acs.2019.06.05.Cloitre A., Duval X., Tubiana S. et al. Antibiotic prophylaxis for the prevention of infective endocarditis for dental procedures is not associated with fatal adverse drug reactions in France. Med Oral Patol Oral Cir Bucal 2019 May 1; 24(3): e296-e304. doi: 10.4317/medoral.22818.Cloitre A., Duval X., Tubiana S. et al. Antibiotic prophylaxis for the prevention of infective endocarditis for dental procedures is not associated with fatal adverse drug reactions in France. Med Oral Patol Oral Cir Bucal 2019 May 1; 24(3): e296-e304. doi: 10.4317/medoral.22818.

The authors declare that there are no conflicts of interest present.